Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Treasury Shares: 2015-2025

Historic Treasury Shares for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $652,267.

  • Editas Medicine's Treasury Shares fell 74.32% to $652,267 in Q3 2025 from the same period last year, while for Sep 2025 it was $652,267, marking a year-over-year decrease of 74.32%. This contributed to the annual value of $2.3 million for FY2024, which is 10.41% up from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Treasury Shares is $652,267, which was down 29.37% from $923,539 recorded in Q2 2025.
  • Editas Medicine's 5-year Treasury Shares high stood at $2.7 million for Q1 2024, and its period low was $628,732 during Q4 2021.
  • Moreover, its 3-year median value for Treasury Shares was $2.1 million (2023), whereas its average is $2.0 million.
  • In the last 5 years, Editas Medicine's Treasury Shares surged by 138.43% in 2022 and then tumbled by 74.32% in 2025.
  • Over the past 5 years, Editas Medicine's Treasury Shares (Quarterly) stood at $628,732 in 2021, then soared by 138.43% to $1.5 million in 2022, then soared by 40.56% to $2.1 million in 2023, then grew by 10.41% to $2.3 million in 2024, then tumbled by 74.32% to $652,267 in 2025.
  • Its last three reported values are $652,267 in Q3 2025, $923,539 for Q2 2025, and $1.5 million during Q1 2025.